FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3848411000001107: Quinidine bisulphate 250mg modified-release tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21766701000001117 Quinidine bisulphate 250mg modified-release tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
75318501000001117 Quinidine bisulfate 250mg modified-release tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Is pack of Quinidine bisulfate 250mg m/r tablet false Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has active ingredient Quinidine bisulfate false Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has VMP Quinidine bisulfate 250mg m/r tablet false Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has specific active ingredient Quinidine bisulfate true Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has VMP Quinidine bisulfate 250mg modified-release tablets false Inferred relationship Existential restriction modifier
Quinidine bisulphate 250mg modified-release tablets 100 tablet Has VMP Quinidine bisulfate 250mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kinidin 250mg Durules (AstraZeneca) 100 tablet 10 x 10 tablets Is a True Quinidine bisulphate 250mg modified-release tablets 100 tablet Inferred relationship Existential restriction modifier
Kinidine 250mg Durettes (PI) (Waymade Ltd) 100 tablet Is a True Quinidine bisulphate 250mg modified-release tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start